This is the user sandbox of Amosabo. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. Create or edit your own sandbox here.

Other sandboxes: Main sandbox | Template sandbox

Finished writing a draft article? Are you ready to request review of it by an experienced editor for possible inclusion in Wikipedia? Submit your draft for review!

S4BE Edit-a-thon Task List

Dos and Donts

This is a suggested task list; feel free to add any topics/tasks you want to the suggested topic section at the bottom. Don't forget to sign it off with your name though (four ~)

If you are the first editor of one of the main topics in our edit-a-thon (no one has signed the tasks within that topic before you; CONGRATULATIONS! You have gained the honour of putting our edit-a-thon banner upon the relevant page! Read here on how to do that.
Most commonly the information worthy of adding will be found in the Plain Language Summary of the Review or in the Author’s Conclusions. Information in the Background section will be very useful in writing up the subject if it is not already mentioned, or fortifying it; try not to add something from the conclusions/summary before reading through the background and identifying any potentially helpful information.

KINDLY DO NOT cut/copy/paste at all! Everything needs to be in your own words and integrated into the article; we are not just adding random pieces of information! We are helping build a comprehensive article; you must:

Read the talk page and understand/ take note of disputed topics and resolved conflicts: the talk page is your friend! When you are not sure about something; ask on the talk page and build consensus.

Just because something is on this list does not necessarily mean it has information that needs to be added; all it means is that it could have information that could be added!

Reviews with new findings will probably have information that can be added, however the findings may be part of a larger subject which is not mentioned in the article, in that case the findings cannot be added without first writing up the relevant subject, use the Background section of the review to help you write it up.

In the case of reviews that have not come to a specific conclusion, or ask for more research to be conducted, these conclusions are not always appropriate for a Wikipedia article. Deciding on whether or not to add them depends on:
- "Not statistically significant", "no evidence to prove", "no findings" does not mean the intervention is not effective! Statistical significance is not the same as clinical significance. Be very careful reporting these conclusions as you may deter people from a potentially valid treatment.
- Is the specific subject mentioned in relevant detail to introduce the recommendations?
- Are the recommendations relevant to an area of research that has current research and will in the near future bear clearer conclusions?
- Is the subject matter of specific importance to practicing physicians/patients or is it more an academic/research based importance?
  In any case, when you are undecided, post a comment on the talk page and get some consensus.

If the review has come to a conclusion that is already mentioned in the article the review can still be added as an extra reference, especially if the previous reference is not a Systematic Review.
It's a good idea that once you finish editing an article you summarize your edits, on the talk page; editing Wikipedia is a collaborative effort.

Most importantly: pick a topic of your liking, take it off the list and add it next to your name, get stuck in, and HAVE FUN!

How to pick a topic and edit this page

Read the Dos and Donts above
Find the subtopic you want to work on (subtopics are in bold) - make sure it isn't one that is already in italics
Edit the page; change the subtopic you want to work on to italics by highlighting it and clicking on the big letter "I" at the top of the editor (or add two single quotes '' before and after it)
Sign your name next to the subtopic (four ~)

Ovarian cancer

Cause; Hormones; Final paragraph; “The link to the use of… ”
- DOI: 10.1002/14651858.CD008215.pub2 [Author’s Conclusions]
Signs and symptoms:
- DOI: 10.1002/14651858.CD009884.pub2 [Background: malnutrition]
Surgery; Final paragraph (“In advance malignancy… ”):
+Diagnosis; Instruments and techniques; Final paragraph (“To definitively diagnose… ”):
- DOI: 10.1002/14651858.CD009786.pub2 [Author’s Conclusion; BUT NO CLEAR CONCLUSION]
- DOI: 10.1002/14651858.CD006014.pub6 [Author’s Conclusions]
Surgery:
- DOI: 10.1002/14651858.CD008765.pub3 [Background + Author’s Conclusions]
Chemotherapy: [Potential for expanding and writing up]
- DOI: 10.1002/14651858.CD005343.pub3 [Add to “In some cases, there may be reason to perform chemotherapy first, followed by surgery]
- DOI: 10.1002/14651858.CD009620.pub2 [Author’s Conclusions]
- DOI: 10.1002/14651858.CD010482.pub2 [Author’s Conclusions]
- DOI: 10.1002/14651858.CD006910.pub2 [Author’s Conclusions]
- DOI: 10.1002/14651858.CD005340.pub3 [currently cites a single RCT (2006) - Author’s Conclusion]
- DOI: 10.1002/14651858.CD004706.pub4 [Full-text]
- ADD New Novel Agents: [Potential for expanding and writing up]
  - DOI: 10.1002/14651858.CD007927.pub3 [Author’s Conclusions]
  - DOI: 10.1002/14651858.CD007930.pub2 [Author’s Conclusions – no evidence but can be added under the new heading]
Immunotherapy: [Potential for expanding and writing up]
- DOI: 10.1002/14651858.CD007287.pub2 [Full-text
Follow-up:
- DOI: 10.1002/14651858.CD006119.pub2 [Full-text]
Palliative care:
- DOI: 10.1002/14651858.CD007792.pub2 [No/limited conclusions]

Migraine

References (and relevant changed information in updates): BLT92 (talk) 12:50, 16 September 2014 (UTC)
- Done Ref 83 (Oct 2010) needs to be updated with the latest version of CD008039 (April 2013)
- Ref 84 (Feb 2012) needs to be updated with the latest version of CD008783 (April 2013)
- Ref 85 (April 2010) needs to be updated with the latest version of CD008041 (April 2013) [Important Conclusion contrary to mentioned]
- Ref 86 (Nov 2011) needs to be updated with the latest version of CD008040 (April 2013)
Prevention; Medication:
- DOI: 10.1002/14651858.CD010609
- DOI: 10.1002/14651858.CD010611
  - Antieplieptics (add?)
    - DOI: 10.1002/14651858.CD010608 [Background + Conclusions]
Management; Triptans:
- DOI: 10.1002/14651858.CD009108.pub2 [Cochrane Overview of Reviews]
- DOI: 10.1002/14651858.CD008616.pub2
- DOI: 10.1002/14651858.CD008541.pub2
Management; Analgesics;
- DOI: 10.1002/14651858.CD009455.pub2
- DOI: 10.1002/14651858.CD008783.pub3 [add reference]
Management; Oxygen therapy (add)
- DOI: 10.1002/14651858.CD005219.pub2

Management of ulcerative colitis

Medications
- Immunosuppressive drugs
  - DOI: 10.1002/14651858.CD006618.pub3
  - DOI: 10.1002/14651858.CD000478.pub3
  - DOI: 10.1002/14651858.CD007560.pub2
  - DOI: 10.1002/14651858.CD004277.pub2
- Monoclonal antibodies [add]
  - DOI: 10.1002/14651858.CD007571.pub2
- Aminosalicylates
  - DOI: 10.1002/14651858.CD004118.pub2
  - DOI: 10.1002/14651858.CD000544.pub3
  - DOI: 10.1002/14651858.CD004115.pub2
- Anticoagulants [add]
- DOI: 10.1002/14651858.CD006774.pub3
- Corticosteroids
  - DOI: 10.1002/14651858.CD007698.pub2
- Treatment for pouchitis [add]
  - DOI: 10.1002/14651858.CD001176.pub2
- Treatment for refractory ulcerative colitis
  - DOI: 10.1002/14651858.CD007216
- Immune modulators [add]
  - DOI: 10.1002/14651858.CD006790.pub2
- TNF inhibitors
  - DOI: 10.1002/14651858.CD005112.pub2
Alternative treatments:
- Herbal medicine
  - Curcumin [add]
    - DOI: 10.1002/14651858.CD008424.pub2
- Probiotics [add]
  - DOI: 10.1002/14651858.CD007443.pub2
  - DOI: 10.1002/14651858.CD005573.pub2
- Fats and oils
  - DOI: 10.1002/14651858.CD005986.pub2
  - DOI: 10.1002/14651858.CD006443.pub2
- Nicotine [add]
  - DOI: 10.1002/14651858.CD004722.pub2
Surgery [Room for expansion]
- DOI: 10.1002/14651858.CD006267.pub2

Crohn's disease

Medications

Comparison of medication
- - DOI: 10.1002/14651858.CD006873.pub2
- Anti-tuberculous therapy
  - DOI: 10.1002/14651858.CD000299
- Azathioprine
  - DOI: 10.1002/14651858.CD010233.pub2
  - DOI: 10.1002/14651858.CD000545.pub4
  - DOI: 10.1002/14651858.CD000067.pub2
- Budesonide
  - DOI: 10.1002/14651858.CD002913.pub3
  - DOI: 10.1002/14651858.CD000296.pub3
- Corticosteroids
  - DOI: 10.1002/14651858.CD006792.pub2
  - DOI: 10.1002/14651858.CD003574.pub2
- Cyclosporine
  - DOI: 10.1002/14651858.CD000297.pub2
- Methotrexate
  - DOI: 10.1002/14651858.CD006884.pub3
  - DOI: 10.1002/14651858.CD003459.pub4
- Naltrexone
  - DOI: 10.1002/14651858.CD010410.pub2
- Natalizumab
  - DOI: 10.1002/14651858.CD006097.pub2
- Olsalazine
  - DOI: 10.1002/14651858.CD008870
- Probiotics
  - DOI: 10.1002/14651858.CD006634.pub2
  - DOI: 10.1002/14651858.CD004826.pub2
- Recombinant human interleukin 10
  - DOI: 10.1002/14651858.CD005109.pub3
- Sargramostim (GM-CSF)
  - DOI: 10.1002/14651858.CD008538.pub2
- Sulfasalazine
  - DOI: 10.1002/14651858.CD008870
- Thalidomide
  - DOI: 10.1002/14651858.CD007351.pub2
  - DOI: 10.1002/14651858.CD007350.pub2
- Tumor necrosis factor-alpha antibody
  - DOI: 10.1002/14651858.CD006893
  - DOI: 10.1002/14651858.CD003574.pub2
- 5-aminosalicylic acid
  - DOI: 10.1002/14651858.CD008414.pub2
  - DOI: 10.1002/14651858.CD003715.pub2
- 6-mercaptopurine
  - DOI: 10.1002/14651858.CD010233.pub2
  - DOI: 10.1002/14651858.CD000545.pub4
  - DOI: 10.1002/14651858.CD000067.pub2

Nutritional supplements

- Omega 3 fatty acids (fish oil)
  - DOI: 10.1002/14651858.CD006320.pub4

Diet

- Enteral nutrition
  - DOI: 10.1002/14651858.CD005984.pub2
  - DOI: 10.1002/14651858.CD000542.pub2

Surgery

- Laparoscopic versus Open surgery for small bowel Crohn's disease
  - DOI: 10.1002/14651858.CD006956.pub2
- Pediatric
  - DOI: 10.1002/14651858.CD004826.pub2

Low back pain

Management:
- ADD Multidisciplinary treatment programs
  - DOI: 10.1002/14651858.CD000963.pub3 [There is one sentence that refers to multidisciplinary rehabilitation for this condition as being of possible benefit: “For those with sub-chronic or chronic low back pain, multidisciplinary treatment programs may help.[39]”. This finding is in line with the Cochrane update findings. The statement is currently referenced (ref 39) rightly and helpfully citing an overview of reviews on multidisciplinary team care in rehabilitation for a range of conditions, including back pain. The overview cites nine Cochrane reviews in fact but not this particular one, which is specifically on chronic low back pain; I think it would be legitimate therefore to add this latest update (Sept 2014) as a reference and perhaps expand that particular sentence with some more detailed findings rather than just “may help”.]

Biopsychosocial model

Model description and application in medicine
- Cochrane review covers multidisciplinary team care and biopsychosocial model of therapy which has a separate article and has [Potential for expanding]:
  - DOI: 10.1002/14651858.CD000963.pub3 [From Low back pain above]
  - DOI: 10.1002/14651858.CD002193 [Mainly Background; old review]
  - DOI: 10.1002/14651858.CD002194 [Mainly Background; old review]

- Mentioned (link to from):

Phimosis

Treatment
- Non-surgical
  DOI: 10.1002/14651858.CD008973.pub2:
  
  "12 studies (1395 boys); incomplete reporting; selection bias, performance & detection bias unclear in majority of studies: 2 had adequate sequence generation, none reported allocation concealment; 2 had adequate blinding of participants & personnel and 1 had high risk of bias; 1 study blinded outcome assessors. Attrition bias was low in 8/12 studies and reporting bias was unclear in 11 studies & high in 1 study."
  
  "Compared with placebo, corticosteroids significantly increased complete or partial clinical resolution of phimosis (12 studies, 1395 participants: RR 2.45, 95% CI 1.84 to 3.26). Studies comparing different types of corticosteroids found that these therapies also significantly increased complete clinical resolution of phimosis (8 studies, 858 participants: RR 3.42, 95% CI 2.08 to 5.62). Although 9 studies (978 participants) reported that assessment of adverse effects were planned in the study design, these outcomes were not reported. Topical corticosteroids offer an effective alternative for treating phimosis in boys. Although sub optimal reporting meant size of effect remains uncertain, corticosteroids appear to be a safe, less invasive first-line treatment option before undertaking surgery to correct phimosis in boys."

Cerebral hemorrhage

Diagnosis amosabo^t@lk; 13:25, 16 September 2014 (UTC)
DOI: 10.1002/14651858.CD009372.pub2

"11 studies (927 participants); partial verification bias in 7/11 (64%) and retrospective designs in 5/10 (50%); small sample sizes."

"In studies of computed tomography angiography (CTA), the pooled estimate of sensitivity was 0.95 (95% confidence interval (CI) 0.90 to 0.97) and specificity was 0.99 (95% CI 0.95 to 1.00). The results remained robust in a sensitivity analysis in which only studies evaluating adult patients (≥ 16 years of age) were included. In studies of magnetic resonance angiography (MRA), the pooled estimate of sensitivity was 0.98 (95% CI 0.80 to 1.00) and specificity was 0.99 (95% CI 0.97 to 1.00). An indirect comparison of CTA and MRA using a bivariate model incorporating test type as one of the parameters failed to reveal a statistically significant difference in sensitivity or specificity between the two imaging modalities (P value = 0.6). CTA and MRA appear to have good sensitivity and specificity following ICH for the detection of intracranial vascular malformations, although several of the included studies had methodological shortcomings (retrospective designs and partial verification bias in particular) that may have increased apparent test accuracy."

Periodic fever, aphthous stomatitis, pharyngitis and adenitis

Treatment amosabo^t@lk; 11:25, 16 September 2014 (UTC)
DOI: 10.1002/14651858.CD008669.pub2

"No studies added. Remains 2 trials (67 children: results from 65 analysed), small sample sizes; both at low risk of bias."

"The evidence for the effectiveness of tonsillectomy in children with PFAPA syndrome is derived from two small randomised controlled trials. These trials reported significant beneficial effects of surgery compared to no surgery on immediate and complete symptom resolution (NNTB = 2) and a substantial reduction in the frequency and severity (length of episode) of any further symptoms experienced. However, the evidence is of moderate quality (further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate) due to the relatively small sample sizes of the studies and some concerns about the applicability of the results. Therefore, the parents and carers of children with PFAPA syndrome must weigh the risks and consequences of surgery against the alternative of using medications. It is well established that children with PFAPA syndrome recover spontaneously and medication can be administered to try and reduce the severity of individual episodes. It is uncertain whether adenoidectomy combined with tonsillectomy adds any additional benefit to tonsillectomy alone."

User:Amosabo/4BE Edit-a-thon Task List

Contents